» Articles » PMID: 17479100

TLR-dependent and TLR-independent Pathways of Type I Interferon Induction in Systemic Autoimmunity

Overview
Journal Nat Med
Date 2007 May 5
PMID 17479100
Citations 222
Authors
Affiliations
Soon will be listed here.
Abstract

We formulate a two-phase paradigm of autoimmunity associated with systemic lupus erythematosus, the archetypal autoimmune disease. The initial Toll-like receptor (TLR)-independent phase is mediated by dendritic cell uptake of apoptotic cell debris and associated nucleic acids, whereas the subsequent TLR-dependent phase serves an amplification function and is mediated by uptake of TLR ligands derived from self-antigens (principally nucleic acids) complexed with autoantibodies. Both phases depend on elaboration of type I interferons (IFNs), and therapeutic interruption of induction or activity of these cytokines in predisposed individuals might have a substantial mitigating effect in lupus and other autoimmune diseases.

Citing Articles

The Role of TLRs in Obesity and Its Related Metabolic Disorders.

Campos-Bayardo T, Roman-Rojas D, Garcia-Sanchez A, Cardona-Munoz E, Sanchez-Lozano D, Totsuka-Sutto S Int J Mol Sci. 2025; 26(5).

PMID: 40076851 PMC: 11900219. DOI: 10.3390/ijms26052229.


Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospects.

Li Z, Liu H, Xie Q, Yin G J Inflamm (Lond). 2024; 21(1):48.

PMID: 39593038 PMC: 11590228. DOI: 10.1186/s12950-024-00422-w.


Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options.

Drougkas K, Skarlis C, Mavragani C Mediterr J Rheumatol. 2024; 35(Suppl 2):365-380.

PMID: 39193187 PMC: 11345602. DOI: 10.31138/mjr.270324.tis.


Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology.

Parker M, Zheng Z, Lasarev M, Larsen M, Vande Loo A, Alexandridis R Ann Rheum Dis. 2024; 83(9):1169-1180.

PMID: 38702176 PMC: 11569393. DOI: 10.1136/ard-2023-224936.


Pharmacological activation of TLR7 exerts inhibition on the replication of EV-D68 in respiratory cells.

Li H, Huang Y, Yang Q, Zhang Z, Shen S, Guo H J Virol. 2024; 98(6):e0043424.

PMID: 38690875 PMC: 11237570. DOI: 10.1128/jvi.00434-24.